Therapeutic potential of AIF-mediated caspase-independent programmed cell death

Drug Resistance Updates

Volumn 10, Issue 6, 2007, Pages 235-255

  Lorenzo, Hans K ^a   Susin, Santos A ^b  

^a INSTITUT ANDRÉ LWOFF   (France)

^b INSTITUT PASTEUR   (France)

Author keywords

AIF; Apoptosis; Calpains; Cancer therapy; Cathepsins; Degenerative diseases; DNA damage; Ischemia; Mitochondria; PARP 1; ROS

Indexed keywords

ABT 888; AFG 495; AG 014699; AK 275; AK 295; APOPTOSIS INDUCING FACTOR; ATIPRIMOD; BALICATIB; BZL101; CALPAIN; CARBOPLATIN; CATHEPSIN; CELECOXIB; CISPLATIN; CLADRIBINE; CRA 013783; DOCETAXEL; ESTRADIOL; ETOPOSIDE; FLAVOPIRIDOL; FLUOROURACIL; GPI 21016; INO 1001; KU 59436; MINOCYCLINE; NICOTINAMIDE; PACLITAXEL POLIGLUMEX; RELACATIB; RWJ 445380; SNJ 1945; THIOCTIC ACID; UNCLASSIFIED DRUG; VORINOSTAT; [1 [(1 FORMYL 2 PHENYLETHYL)CARBAMOYL] 2 METHYLPROPYL]CARBAMIC ACID BENZYL ESTER;

AMYOTROPHIC LATERAL SCLEROSIS; APOPTOSIS; ARTICLE; ATAXIA TELANGIECTASIA; BRAIN ISCHEMIA; CANCER CELL; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL TRIAL; HEART MUSCLE ISCHEMIA; HEMATOLOGIC MALIGNANCY; HUMAN; LUNG CARCINOMA; LUNG SMALL CELL CANCER; METASTASIS; MULTIPLE MYELOMA; NONHUMAN; OSTEOARTHRITIS; OVARY CANCER; PANCREAS CANCER; PLASMACYTOMA; PRIORITY JOURNAL; PROSTATE CANCER; RHEUMATOID ARTHRITIS; SOLID TUMOR; UTERINE CERVIX CANCER;

EID: 38549123294     PISSN: 13687646     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drup.2007.11.001     Document Type: Article

References (253)

1. Aarts M., Iihara K., Wei W.L., Xiong Z.G., Arundine M., Cerwinski W., MacDonald J.F., and Tymianski M. A key role for TRPM7 channels in anoxic neuronal death. Cell 115 (2003) 863-877
2. Abu El-Asrar A.M., Dralands L., Missotten L., and Geboes K. Expression of antiapoptotic and proapoptotic molecules in diabetic retinas. Eye 21 (2007) 238-245
3. Albain K.S., Belani C.P., Bonomi P., O'Byrne K.J., Schiller J.H., and Socinski M. PIONEER: a phase III randomized trial of paclitaxel poliglumex versus paclitaxel in chemotherapy-naive women with advanced-stage non-small-cell lung cancer and performance status of 2. Clin. Lung Cancer 7 (2006) 417-419
4. Araujo I.M., Xapelli S., Gil J.M., Mohapel P., Petersen A., Pinheiro P.S., Malva J.O., Bahr B.A., Brundin P., and Carvalho C.M. Proteolysis of NR2B by calpain in the hippocampus of epileptic rats. Neuroreport 16 (2005) 393-396
5. Arnoult D., Tatischeff I., Estaquier J., Girard M., Sureau F., Tissier J.P., et al. On the evolutionary conservation of the cell death pathway: mitochondrial release of an apoptosis-inducing factor during Dictyostelium discoideum cell death. Mol. Biol. Cell 12 (2001) 3016-3030
6. Artal-Sanz M., and Tavernarakis N. Proteolytic mechanisms in necrotic cell death and neurodegeneration. FEBS Lett. 579 (2005) 3287-3296
7. Artus C., Maquarre E., Moubarak R.S., Delettre C., Jasmin C., Susin S.A., and Robert-Lezenes J. CD44 ligation induces caspase-independent cell death via a novel calpain/AIF pathway in human erythroleukemia cells. Oncogene 25 (2006) 5741-5751
8. Bahi N., Zhang J., Llovera M., Ballester M., Comella J.X., and Sanchis D. Switch from caspase-dependent to caspase-independent death during heart development: essential role of Endonuclease G in ischemia-induced DNA processing of differentiated cardiomyocytes. J. Biol. Chem. 281 (2006) 22943-22952
9. Barkla D.H., and Gibson P.R. The fate of epithelial cells in the human large intestine. Pathology 31 (1999) 230-238
10. Bartus R.T., Baker K.L., Heiser A.D., Sawyer S.D., Dean R.L., Elliott P.J., and Straub J.A. Postischemic administration of AK275, a calpain inhibitor, provides substantial protection against focal ischemic brain damage. J. Cereb. Blood Flow Metab. 14 (1994) 537-544
11. Becattini B., Culmsee C., Leone M., Zhai D., Zhang X., Crowell K.J., Rega M.F., Landshamer S., Reed J.C., Plesnila N., and Pellecchia M. Structure-activity relationships by interligand NOE-based design and synthesis of antiapoptotic compounds targeting Bid. Proc. Natl. Acad. Sci. U.S.A. 103 (2006) 12602-12606
12. Beere H.M., Wolf B.B., Cain K., Mosser D.D., Mahboubi A., Kuwana T., Tailor P., Morimoto R.I., Cohen G.M., and Green D.R. Heat-shock protein 70 inhibits apoptosis by preventing recruitment of procaspase-9 to the Apaf-1 apoptosome. Nat. Cell Biol. 2 (2000) 469-475
13. Bidere N., Lorenzo H.K., Carmona S., Laforge M., Harper F., Dumont C., and Senik A. Cathepsin D triggers Bax activation, resulting in selective apoptosis-inducing factor (AIF) relocation in T lymphocytes entering the early commitment phase to apoptosis. J. Biol. Chem. 278 (2003) 31401-31411
14. Bizat N., Galas M.C., Jacquard C., Boyer F., Hermel J.M., Schiffmann S.N., Hantraye P., Blum D., and Brouillet E. Neuroprotective effect of zVAD against the neurotoxin 3-nitropropionic acid involves inhibition of calpain. Neuropharmacology 49 (2005) 695-702
15. Blagosklonny M.V. Prospective strategies to enforce selectively cell death in cancer cells. Oncogene 23 (2004) 2967-2975
16. Borst P., and Rottenberg S. Cancer cell death by programmed necrosis?. Drug Resist. Updates 7 (2004) 321-324
17. Boujrad H., Gubkina O., Robert N., Krantic S., and Susin S.A. AIF-mediated programmed necrosis: A highly regulated way to die. Cell Cycle 6 (2007) 2611-2618
18. Boya P., Gonzalez-Polo R.A., Casares N., Perfettini J.L., Dessen P., Larochette N., et al. Inhibition of macroautophagy triggers apoptosis. Mol. Cell. Biol. 25 (2005) 1025-1040
19. Boya P., Gonzalez-Polo R.A., Poncet D., Andreau K., Vieira H.L., Roumier T., Perfettini J.L., and Kroemer G. Mitochondrial membrane permeabilization is a critical step of lysosome-initiated apoptosis induced by hydroxychloroquine. Oncogene 22 (2003) 3927-3936
20. Bras M., Yuste V.J., Roue G., Barbier S., Sancho P., Virely C., Rubio M., Baudet S., Esquerda J.E., Merle-Beral H., Sarfati M., and Susin S.A. Drp1 mediates caspase-independent type III cell death in normal and leukemic cells. Mol. Cell. Biol. 27 (2007) 7073-7088
21. Braun J.S., Novak R., Murray P.J., Eischen C.M., Susin S.A., Kroemer G., Halle A., Weber J.R., Tuomanen E.I., and Cleveland J.L. Apoptosis-inducing factor mediates microglial and neuronal apoptosis caused by pneumococcus. J. Infect. Dis. 184 (2001) 1300-1309
22. Bröker L.E., Huisman C., Span S.W., Rodriguez J.A., Kruyt F.A., and Giaccone G. Cathepsin B mediates caspase-independent cell death induced by microtubule stabilizing agents in non-small cell lung cancer cells. Cancer Res. 64 (2004) 27-30
23. Bröker L.E., Kruyt F.A., and Giaccone G. Cell death independent of caspases: a review. Clin. Cancer Res. 11 (2005) 3155-3162
24. Brown D., Yu B.D., Joza N., Benit P., Meneses J., Firpo M., Rustin P., Penninger J.M., and Martin G.R. Loss of Aif function causes cell death in the mouse embryo, but the temporal progression of patterning is normal. Proc. Natl. Acad. Sci. U.S.A. 103 (2006) 9918-9923
25. Cande C., Vahsen N., Kouranti I., Schmitt E., Daugas E., Spahr C., Luban J., Kroemer R.T., Giordanetto F., Garrido C., Penninger J.M., and Kroemer G. AIF and cyclophilin A cooperate in apoptosis-associated chromatinolysis. Oncogene 23 (2004) 1514-1521
26. Cao G., Xing J., Xiao X., Liou A.K., Gao Y., Yin X.M., Clark R.S., Graham S.H., and Chen J. Critical role of calpain I in mitochondrial release of apoptosis-inducing factor in ischemic neuronal injury. J. Neurosci. 27 (2007) 9278-9293
27. Cao X., Deng X., and May W.S. Cleavage of Bax to p18 Bax accelerates stress-induced apoptosis, and a cathepsin-like protease may rapidly degrade p18 Bax. Blood 102 (2003) 2605-2614
28. Cartron P.F., Oliver L., Juin P., Meflah K., and Vallette F.M. The p18 truncated form of Bax behaves like a Bcl-2 homology domain 3-only protein. J. Biol. Chem. 279 (2004) 11503-11512
29. Casley C.S., Land J.M., Sharpe M.A., Clark J.B., Duchen M.R., and Canevari L. Beta-amyloid fragment 25-35 causes mitochondrial dysfunction in primary cortical neurons. Neurobiol. Dis. 10 (2002) 258-267
30. Chautan M., Chazal G., Cecconi F., Gruss P., and Golstein P. Interdigital cell death can occur through a necrotic and caspase-independent pathway. Curr. Biol. 9 (1999) 967-970
31. Chen M., He H., Zhan S., Krajewski S., Reed J.C., and Gottlieb R.A. Bid is cleaved by calpain to an active fragment in vitro and during myocardial ischemia/reperfusion. J. Biol. Chem. 276 (2001) 30724-30728
32. Chen M., Zsengeller Z., Xiao C.Y., and Szabo C. Mitochondrial-to-nuclear translocation of apoptosis-inducing factor in cardiac myocytes during oxidant stress: potential role of poly(ADP-ribose) polymerase-1. Cardiovasc. Res. 63 (2004) 682-688
33. Chen W., Li N., Chen T., Han Y., Li C., Wang Y., He W., Zhang L., Wan T., and Cao X. The lysosome-associated apoptosis-inducing protein containing the pleckstrin homology (PH) and FYVE domains (LAPF), representative of a novel family of PH and FYVE domain-containing proteins, induces caspase-independent apoptosis via the lysosomal-mitochondrial pathway. J. Biol. Chem. 280 (2005) 40985-40995
34. Chen W., Yang S., Abe Y., Li M., Wang Y., Shao J., Li E., and Li Y.P. Novel pycnodysostosis mouse model uncovers cathepsin K function as a potential regulator of osteoclast apoptosis and senescence. Hum. Mol. Genet. 16 (2007) 410-423
35. Cheung E.C., Joza N., Steenaart N.A., McClellan K.A., Neuspiel M., McNamara S., et al. Dissociating the dual roles of apoptosis-inducing factor in maintaining mitochondrial structure and apoptosis. EMBO J. 25 (2006) 4061-4073
36. Cheung E.C., Melanson-Drapeau L., Cregan S.P., Vanderluit J.L., Ferguson K.L., McIntosh W.C., Park D.S., Bennett S.A., and Slack R.S. Apoptosis-inducing factor is a key factor in neuronal cell death propagated by BAX-dependent and BAX-independent mechanisms. J. Neurosci. 25 (2005) 1324-1334
37. Chiarugi A. Poly(ADP-ribosyl)ation and stroke. Pharmacol. Res. 52 (2005) 15-24
38. Chipman S.D., Oldham F.B., Pezzoni G., and Singer J.W. Biological and clinical characterization of paclitaxel poliglumex (PPX, CT-2103), a macromolecular polymer-drug conjugate. Int. J. Nanomed. 1 (2006) 375-383
39. Clarke M., Bennett M., and Littlewood T. Cell death in the cardiovascular system. Heart 93 (2007) 659-664
40. Clarke P.G. Developmental cell death: morphological diversity and multiple mechanisms. Anat. Embryol. 181 (1990) 195-213
41. Codogno P., and Meijer A.J. Autophagy and signaling: their role in cell survival and cell death. Cell Death Differ. 12 Suppl. 2 (2005) 1509-1518
42. Cohen J.J. Apoptosis: the physiologic pathway of cell death. Hosp. Pract. (Off Ed.) 28 (1993) 35-43
43. Colbourne F., Sutherland G.R., and Auer R.N. Electron microscopic evidence against apoptosis as the mechanism of neuronal death in global ischemia. J. Neurosci. 19 (1999) 4200-4210
44. Corbiere C., Liagre B., Terro F., and Beneytout J.L. Induction of antiproliferative effect by diosgenin through activation of p53, release of apoptosis-inducing factor (AIF) and modulation of caspase-3 activity in different human cancer cells. Cell Res. 14 (2004) 188-196
45. Cregan S.P., Dawson V.L., and Slack R.S. Role of AIF in caspase-dependent and caspase-independent cell death. Oncogene 23 (2004) 2785-2796
46. Cregan S.P., Fortin A., MacLaurin J.G., Callaghan S.M., Cecconi F., Yu S.W., Dawson T.M., Dawson V.L., Park D.S., Kroemer G., and Slack R.S. Apoptosis-inducing factor is involved in the regulation of caspase-independent neuronal cell death. J. Cell Biol. 158 (2002) 507-517
47. Crocker S.J., Smith P.D., Jackson-Lewis V., Lamba W.R., Hayley S.P., Grimm E., et al. Inhibition of calpains prevents neuronal and behavioral deficits in an MPTP mouse model of Parkinson's disease. J. Neurosci. 23 (2003) 4081-4091
48. Cuerrier D., Moldoveanu T., and Davies P.L. Determination of peptide substrate specificity for mu-calpain by a peptide library-based approach: the importance of primed side interactions. J. Biol. Chem. 280 (2005) 40632-40641
49. Cuerrier D., Moldoveanu T., Inoue J., Davies P.L., and Campbell R.L. Calpain inhibition by alpha-ketoamide and cyclic hemiacetal inhibitors revealed by X-ray crystallography. Biochemistry 45 (2006) 7446-7452
50. Culmsee C., and Plesnila N. Targeting Bid to prevent programmed cell death in neurons. Biochem. Soc. Trans. 34 (2006) 1334-1340
51. Culmsee C., Zhu C., Landshamer S., Becattini B., Wagner E., Pellecchia M., Blomgren K., and Plesnila N. Apoptosis-inducing factor triggered by poly(ADP-ribose) polymerase and Bid mediates neuronal cell death after oxygen-glucose deprivation and focal cerebral ischemia. J. Neurosci. 25 (2005) 10262-10272
52. Danial N.N., and Korsmeyer S.J. Cell death: critical control points. Cell 116 (2004) 205-219
53. Daugaard M., Rohde M., and Jaattela M. The heat shock protein 70 family: highly homologous proteins with overlapping and distinct functions. FEBS Lett. 581 (2007) 3702-3710
54. Daugas E., Nochy D., Ravagnan L., Loeffler M., Susin S.A., Zamzami N., and Kroemer G. Apoptosis-inducing factor (AIF): a ubiquitous mitochondrial oxidoreductase involved in apoptosis. FEBS Lett. 476 (2000) 118-123
55. Delettre C., Yuste V.J., Moubarak R.S., Bras M., Lesbordes-Brion J.C., Petres S., Bellalou J., and Susin S.A. AIFsh, a novel apoptosis-inducing factor (AIF) pro-apoptotic isoform with potential pathological relevance in human cancer. J. Biol. Chem. 281 (2006) 6413-6427
56. Delettre C., Yuste V.J., Moubarak R.S., Bras M., Robert N., and Susin S.A. Identification and characterization of AIFsh2, a mitochondrial apoptosis-inducing factor (AIF) isoform with NADH Oxidase activity. J. Biol. Chem. 281 (2006) 18507-18518
57. Di Napoli P., Taccardi A.A., Grilli A., Felaco M., Balbone A., Angelucci D., et al. Left ventricular wall stress as a direct correlate of cardiomyocyte apoptosis in patients with severe dilated cardiomyopathy. Am. Heart J. 146 (2003) 1105-1111
58. Didenko V.V., Ngo H., Minchew C.L., Boudreaux D.J., Widmayer M.A., and Baskin D.S. Caspase-3-dependent and -independent apoptosis in focal brain ischemia. Mol. Med. 8 (2002) 347-352
59. Ding Y., Zhou Y., Lai Q., Li J., Gordon V., and Diaz F.G. Long-term neuroprotective effect of inhibiting poly(ADP-ribose) polymerase in rats with middle cerebral artery occlusion using a behavioral assessment. Brain Res. 915 (2001) 210-217
60. Dumont C., Durrbach A., Bidere N., Rouleau M., Kroemer G., Bernard G., Hirsch F., Charpentier B., Susin S.A., and Senik A. Caspase-independent commitment phase to apoptosis in activated blood T lymphocytes: reversibility at low apoptotic insult. Blood 96 (2000) 1030-1038
61. El Ghouzzi V., Csaba Z., Olivier P., Lelouvier B., Schwendimann L., Dournaud P., Verney C., Rustin P., and Gressens P. Apoptosis-inducing factor deficiency induces early mitochondrial degeneration in brain followed by progressive multifocal neuropathology. J. Neuropathol. Exp. Neurol. 66 (2007) 838-847
62. Emert-Sedlak L., Shangary S., Rabinovitz A., Miranda M.B., Delach S.M., and Johnson D.E. Involvement of cathepsin D in chemotherapy-induced cytochrome c release, caspase activation, and cell death. Mol. Cancer Ther. 4 (2005) 733-742
63. Fehrenbacher N., and Jaattela M. Lysosomes as targets for cancer therapy. Cancer Res. 65 (2005) 2993-2995
64. Ferri K.F., Jacotot E., Blanco J., Este J.A., Zamzami N., Susin S.A., Xie Z., Brothers G., Reed J.C., Penninger J.M., and Kroemer G. Apoptosis control in syncytia induced by the HIV type 1-envelope glycoprotein complex: role of mitochondria and caspases. J. Exp. Med. 192 (2000) 1081-1092
65. Festjens N., Vanden Berghe T., and Vandenabeele P. Necrosis, a well-orchestrated form of cell demise: signalling cascades, important mediators and concomitant immune response. Biochim. Biophys. Acta 1757 (2006) 1371-1387
66. Fombonne J., Padron L., Enjalbert A., Krantic S., and Torriglia A. A novel paraptosis pathway involving LEI/L-DNaseII for EGF-induced cell death in somato-lactotrope pituitary cells. Apoptosis 11 (2006) 367-375
67. Fujikawa D.G., Shinmei S.S., and Cai B. Seizure-induced neuronal necrosis: implications for programmed cell death mechanisms. Epilepsia 41 Suppl. 6 (2000) S9-S13
68. Fukunaga K., Han F., Shioda N., Moriguchi S., Kasahara J., and Shirasaki Y. DY-9760e, a novel calmodulin inhibitor, exhibits cardioprotective effects in the ischemic heart. Cardiovasc. Drug Rev. 24 (2006) 88-100
69. Furre I.E., Shahzidi S., Luksiene Z., Moller M.T., Borgen E., Morgan J., Tkacz-Stachowska K., Nesland J.M., and Peng Q. Targeting PBR by hexaminolevulinate-mediated photodynamic therapy induces apoptosis through translocation of apoptosis-inducing factor in human leukemia cells. Cancer Res. 65 (2005) 11051-11060
70. Gallego M.A., Joseph B., Hemstrom T.H., Tamiji S., Mortier L., Kroemer G., Formstecher P., Zhivotovsky B., and Marchetti P. Apoptosis-inducing factor determines the chemoresistance of non-small-cell lung carcinomas. Oncogene 23 (2004) 6282-6291
71. Gocheva V., and Joyce J.A. Cysteine cathepsins and the cutting edge of cancer invasion. Cell Cycle 6 (2007) 60-64
72. Gogvadze V., Orrenius S., and Zhivotovsky B. Multiple pathways of cytochrome c release from mitochondria in apoptosis. Biochim. Biophys. Acta 1757 (2006) 639-647
73. Goll D.E., Thompson V.F., Li H., Wei W., and Cong J. The calpain system. Physiol. Rev. 83 (2003) 731-801
74. Golstein P., Aubry L., and Levraud J.P. Cell-death alternative model organisms: why and which?. Nat. Rev. Mol. Cell. Biol. 4 (2003) 798-807
75. Golstein P., and Kroemer G. A multiplicity of cell death pathways. Symposium on Apoptotic and Non-Apoptotic Cell Death Pathways. EMBO Rep. 8 (2007) 829-833
76. Golstein P., and Kroemer G. Cell death by necrosis: towards a molecular definition. Trends Biochem. Sci. 32 (2007) 37-43
77. Goto S., Xue R., Sugo N., Sawada M., Blizzard K.K., Poitras M.F., et al. Poly(ADP-ribose) polymerase impairs early and long-term experimental stroke recovery. Stroke 33 (2002) 1101-1106
78. Gozuacik D., and Kimchi A. Autophagy and cell death. Curr. Top. Dev. Biol. 78 (2007) 217-245
79. Green D.R., and Reed J.C. Mitochondria and apoptosis. Science 281 (1998) 1309-1312
80. Gross A., McDonnell J.M., and Korsmeyer S.J. BCL-2 family members and the mitochondria in apoptosis. Genes Dev. 13 (1999) 1899-1911
81. Guicciardi M.E., Deussing J., Miyoshi H., Bronk S.F., Svingen P.A., Peters C., Kaufmann S.H., and Gores G.J. Cathepsin B contributes to TNF-alpha-mediated hepatocyte apoptosis by promoting mitochondrial release of cytochrome c. J. Clin. Invest. 106 (2000) 1127-1137
82. Gurbuxani S., Schmitt E., Cande C., Parcellier A., Hammann A., Daugas E., et al. Heat shock protein 70 binding inhibits the nuclear import of apoptosis-inducing factor. Oncogene 22 (2003) 6669-6678
83. Ha H.C., and Snyder S.H. Poly(ADP-ribose) polymerase is a mediator of necrotic cell death by ATP depletion. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 13978-13982
84. Haince J.F., Rouleau M., Hendzel M.J., Masson J.Y., and Poirier G.G. Targeting poly(ADP-ribosyl)ation: a promising approach in cancer therapy. Trends Mol. Med. 11 (2005) 456-463
85. Han F., Shirasaki Y., and Fukunaga K. 3-[2-[4-(3-Chloro-2-methylphenylmethyl)-1-piperazinyl]ethyl]-5.6-dimethoxy -1-(4-imidazolylmethyl)-1H-indazole dihydro-chloride 3. 5 hydrate (DY-9760e) is neuroprotective in rat microsphere embolism: role of the cross-talk between calpain and caspase-3 through calpastatin. J. Pharmacol. Exp. Ther. 317 (2006) 529-536
86. Han W., Li L., Qiu S., Lu Q., Pan Q., Gu Y., Luo J., and Hu X. Shikonin circumvents cancer drug resistance by induction of a necroptotic death. Mol. Cancer Ther. 6 (2007) 1641-1649
87. Heinrich M., Neumeyer J., Jakob M., Hallas C., Tchikov V., Winoto-Morbach S., et al. Cathepsin D links TNF-induced acid sphingomyelinase to Bid-mediated caspase-9 and -3 activation. Cell Death Differ. 11 (2004) 550-563
88. Hengartner M.O. The biochemistry of apoptosis. Nature 407 (2000) 770-776
89. Henry-Mowatt J., Dive C., Martinou J.C., and James D. Role of mitochondrial membrane permeabilization in apoptosis and cancer. Oncogene 23 (2004) 2850-2860
90. Hisatomi T., Sakamoto T., Murata T., Yamanaka I., Oshima Y., Hata Y., Ishibashi T., Inomata H., Susin S.A., and Kroemer G. Relocalization of apoptosis-inducing factor in photoreceptor apoptosis induced by retinal detachment in vivo. Am. J. Pathol. 158 (2001) 1271-1278
91. Holler N., Zaru R., Micheau O., Thome M., Attinger A., Valitutti S., et al. Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule. Nat. Immunol. 1 (2000) 489-495
92. Hong S.J., Dawson T.M., and Dawson V.L. Nuclear and mitochondrial conversations in cell death: PARP-1 and AIF signaling. Trends Pharmacol. Sci. 25 (2004) 259-264
93. Hong S.W., Jin D.H., Hahm E.S., Yim S.H., Lim J.S., Kim K.I., et al. Ascorbate (vitamin C) induces cell death through the apoptosis-inducing factor in human breast cancer cells. Oncol. Rep. 18 (2007) 811-815
94. Houseweart M.K., Vilaythong A., Yin X.M., Turk B., Noebels J.L., and Myers R.M. Apoptosis caused by cathepsins does not require Bid signaling in an in vivo model of progressive myoclonus epilepsy (EPM1). Cell Death Differ. 10 (2003) 1329-1335
95. Hu W., and Kavanagh J.J. Anticancer therapy targeting the apoptotic pathway. Lancet Oncol. 4 (2003) 721-729
96. Ichinose S., Usuda J., Hirata T., Inoue T., Ohtani K., Maehara S., et al. Lysosomal cathepsin initiates apoptosis, which is regulated by photodamage to Bcl-2 at mitochondria in photodynamic therapy using a novel photosensitizer, ATX-s10 (Na). Int. J. Oncol. 29 (2006) 349-355
97. Isacson O. On neuronal health. Trends Neurosci. 16 (1993) 306-308
98. Iwashita A., Tojo N., Matsuura S., Yamazaki S., Kamijo K., Ishida J., et al. A novel and potent poly(ADP-ribose) polymerase-1 inhibitor, FR247304 (5-chloro-2-[3-(4-phenyl-3,6-dihydro-1(2H)-pyridinyl)propyl]-4(3H)-quinazo linone), attenuates neuronal damage in in vitro and in vivo models of cerebral ischemia. J. Pharmacol. Exp. Ther. 310 (2004) 425-436
99. Jaattela M. Programmed cell death: many ways for cells to die decently. Ann. Med. 34 (2002) 480-488
100. Jaattela M., and Tschopp J. Caspase-independent cell death in T lymphocytes. Nat. Immunol. 4 (2003) 416-423
101. Joyce J.A., Baruch A., Chehade K., Meyer-Morse N., Giraudo E., Tsai F.Y., et al. Cathepsin cysteine proteases are effectors of invasive growth and angiogenesis during multistage tumorigenesis. Cancer Cell 5 (2004) 443-453
102. Joza N., Oudit G.Y., Brown D., Benit P., Kassiri Z., Vahsen N., et al. Muscle-specific loss of apoptosis-inducing factor leads to mitochondrial dysfunction, skeletal muscle atrophy, and dilated cardiomyopathy. Mol. Cell. Biol. 25 (2005) 10261-10272
103. Joza N., Susin S.A., Daugas E., Stanford W.L., Cho S.K., Li C.Y., et al. Essential role of the mitochondrial apoptosis-inducing factor in programmed cell death. Nature 410 (2001) 549-554
104. Kabra D.G., Thiyagarajan M., Kaul C.L., and Sharma S.S. Neuroprotective effect of 4-amino-1,8-napthalimide, a poly(ADP ribose) polymerase inhibitor in middle cerebral artery occlusion-induced focal cerebral ischemia in rat. Brain Res. Bull. 62 (2004) 425-433
105. Kagedal K., Johansson A.C., Johansson U., Heimlich G., Roberg K., Wang N.S., Jurgensmeier J.M., and Ollinger K. Lysosomal membrane permeabilization during apoptosis-involvement of Bax?. Int. J. Exp. Pathol. 86 (2005) 309-321
106. Kagedal K., Zhao M., Svensson I., and Brunk U.T. Sphingosine-induced apoptosis is dependent on lysosomal proteases. Biochem. J. 359 (2001) 335-343
107. Kang Y.H., Yi M.J., Kim M.J., Park M.T., Bae S., Kang C.M., et al. Caspase-independent cell death by arsenic trioxide in human cervical cancer cells: reactive oxygen species-mediated poly(ADP-ribose) polymerase-1 activation signals apoptosis-inducing factor release from mitochondria. Cancer Res. 64 (2004) 8960-8967
108. Kaufmann S.H., and Vaux D.L. Alterations in the apoptotic machinery and their potential role in anticancer drug resistance. Oncogene 22 (2003) 7414-7430
109. Keeney P.M., Xie J., Capaldi R.A., and Bennett Jr. J.P. Parkinson's disease brain mitochondrial complex I has oxidatively damaged subunits and is functionally impaired and misassembled. J. Neurosci. 26 (2006) 5256-5264
110. Keil C., Grobe T., and Oei S.L. MNNG-induced cell death is controlled by interactions between PARP-1, poly(ADP-ribose) glycohydrolase, and XRCC1. J. Biol. Chem. 281 (2006) 34394-34405
111. Kerr J.F., Winterford C.M., and Harmon B.V. Apoptosis. Its significance in cancer and cancer therapy. Cancer 73 (1994) 2013-2026
112. Kerr J.F., Wyllie A.H., and Currie A.R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer 26 (1972) 239-257
113. Kim G.T., Chun Y.S., Park J.W., and Kim M.S. Role of apoptosis-inducing factor in myocardial cell death by ischemia-reperfusion. Biochem. Biophys. Res. Commun. 309 (2003) 619-624
114. Kitareewan S., Roebuck B.D., Demidenko E., Sloboda R.D., and Dmitrovsky E. Lysosomes and trivalent arsenic treatment in acute promyelocytic leukemia. J. Natl. Cancer Inst. 99 (2007) 41-52
115. Klein J.A., Longo-Guess C.M., Rossmann M.P., Seburn K.L., Hurd R.E., Frankel W.N., Bronson R.T., and Ackerman S.L. The harlequin mouse mutation downregulates apoptosis-inducing factor. Nature 419 (2002) 367-374
116. Koh D.W., Dawson T.M., and Dawson V.L. Mediation of cell death by poly(ADP-ribose) polymerase-1. Pharmacol. Res. 52 (2005) 5-14
117. Komjati K., Mabley J.G., Virag L., Southan G.J., Salzman A.L., and Szabo C. Poly(ADP-ribose) polymerase inhibition protect neurons and the white matter and regulates the translocation of apoptosis-inducing factor in stroke. Int. J. Mol. Med. 13 (2004) 373-382
118. Koonin E.V., and Aravind L. Origin and evolution of eukaryotic apoptosis: the bacterial connection. Cell Death Differ. 9 (2002) 394-404
119. Krantic S., Mechawar N., Reix S., and Quirion R. Apoptosis-inducing factor: a matter of neuron life and death. Prog. Neurobiol. 81 (2007) 179-196
120. Krantic S., Mechawar N., Reix S., and Quirion R. Molecular basis of programmed cell death involved in neurodegeneration. Trends Neurosci. 28 (2005) 670-676
121. Kroemer G., El-Deiry W.S., Golstein P., Peter M.E., Vaux D., Vandenabeele P., et al. Classification of cell death: recommendations of the nomenclature committee on cell death. Cell Death Differ. 12 Suppl. 2 (2005) 1463-1467
122. Kroemer G., Zamzami N., and Susin S.A. Mitochondrial control of apoptosis. Immunol. Today 18 (1997) 44-51
123. Kuwana T., Mackey M.R., Perkins G., Ellisman M.H., Latterich M., Schneiter R., Green D.R., and Newmeyer D.D. Bid, Bax, and lipids cooperate to form supramolecular openings in the outer mitochondrial membrane. Cell 111 (2002) 331-342
124. Le D.A., Wu Y., Huang Z., Matsushita K., Plesnila N., Augustinack J.C., et al. Caspase activation and neuroprotection in caspase-3-deficient mice after in vivo cerebral ischemia and in vitro oxygen glucose deprivation. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 15188-15193
125. Lee B.I., Chan P.H., and Kim G.W. Metalloporphyrin-based superoxide dismutase mimic attenuates the nuclear translocation of apoptosis-inducing factor and the subsequent DNA fragmentation after permanent focal cerebral ischemia in mice. Stroke 36 (2005) 2712-2717
126. Lee J.H., Park S.Y., Shin H.K., Kim C.D., Lee W.S., and Hong K.W. Poly(ADP-ribose) polymerase inhibition by cilostazol is implicated in the neuroprotective effect against focal cerebral ischemic infarct in rat. Brain Res. 1152 (2007) 182-190
127. Leist M., and Jaattela M. Four deaths and a funeral: from caspases to alternative mechanisms. Nat. Rev. Mol. Cell. Biol. 2 (2001) 589-598
128. Letai A., Bassik M.C., Walensky L.D., Sorcinelli M.D., Weiler S., and Korsmeyer S.J. Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics. Cancer Cell 2 (2002) 183-192
129. Li L., Han W., Gu Y., Qiu S., Lu Q., Jin J., Luo J., and Hu X. Honokiol induces a necrotic cell death through the mitochondrial permeability transition pore. Cancer Res. 67 (2007) 4894-4903
130. Li W., Yuan X., Nordgren G., Dalen H., Dubowchik G.M., Firestone R.A., and Brunk U.T. Induction of cell death by the lysosomotropic detergent MSDH. FEBS Lett. 470 (2000) 35-39
131. Li X., Nemoto M., Xu Z., Yu S.W., Shimoji M., Andrabi S.A., Haince J.F., et al. Influence of duration of focal cerebral ischemia and neuronal nitric oxide synthase on translocation of apoptosis-inducing factor to the nucleus. Neuroscience 144 (2007) 56-65
132. Linder S., and Shoshan M.C. Lysosomes and endoplasmic reticulum: targets for improved, selective anticancer therapy. Drug Resist. Updates 8 (2005) 199-204
133. Littlewood T.D., and Bennett M.R. Apoptotic cell death in atherosclerosis. Curr. Opin. Lipidol. 14 (2003) 469-475
134. Liu P.L., Chen Y.L., Chen Y.H., Lin S.J., and Kou Y.R. Wood smoke extract induces oxidative stress-mediated caspase-independent apoptosis in human lung endothelial cells: role of AIF and EndoG. Am. J. Physiol. Lung Cell. Mol. Physiol. 289 (2005) L739-L749
135. Liu T., Brouha B., and Grossman D. Rapid induction of mitochondrial events and caspase-independent apoptosis in Survivin-targeted melanoma cells. Oncogene 23 (2004) 39-48
136. Loeffler M., Daugas E., Susin S.A., Zamzami N., Metivier D., Nieminen A.L., Brothers G., Penninger J.M., and Kroemer G. Dominant cell death induction by extramitochondrially targeted apoptosis-inducing factor. FASEB J. 15 (2001) 758-767
137. Lorenzo H.K., and Susin S.A. Mitochondrial effectors in caspase-independent cell death. FEBS Lett. 557 (2004) 14-20
138. Lorenzo H.K., Susin S.A., Penninger J., and Kroemer G. Apoptosis inducing factor (AIF): a phylogenetically old, caspase-independent effector of cell death. Cell Death Differ. 6 (1999) 516-524
139. Maddika S., Ande S.R., Panigrahi S., et al. Cell survival, cell death and cell cycle pathways are interconnected: implications for cancer therapy. Drug Resist. Updates 10 (2007) 13-29
140. Markgraf C.G., Velayo N.L., Johnson M.P., McCarty D.R., Medhi S., Koehl J.R., Chmielewski P.A., and Linnik M.D. Six-hour window of opportunity for calpain inhibition in focal cerebral ischemia in rats. Stroke 29 (1998) 152-158
141. Martinou J.C., and Green D.R. Breaking the mitochondrial barrier. Nat. Rev. Mol. Cell. Biol. 2 (2001) 63-67
142. Mashima T., and Tsuruo T. Defects of the apoptotic pathway as therapeutic target against cancer. Drug Resist. Updates 8 (2005) 339-343
143. Mate M.J., Ortiz-Lombardia M., Boitel B., Haouz A., Tello D., Susin S.A., Penninger J., Kroemer G., and Alzari P.M. The crystal structure of the mouse apoptosis-inducing factor AIF. Nat. Struct. Biol. 9 (2002) 442-446
144. Matsumori Y., Hong S.M., Aoyama K., Fan Y., Kayama T., Sheldon R.A., et al. Hsp70 overexpression sequesters AIF and reduces neonatal hypoxic/ischemic brain injury. J. Cereb. Blood Flow Metab. 25 (2005) 899-910
145. Melino G., Knight R.A., and Nicotera P. How many ways to die? How many different models of cell death?. Cell Death Differ. 12 Suppl. 2 (2005) 1457-1462
146. Miramar M.D., Costantini P., Ravagnan L., Saraiva L.M., Haouzi D., Brothers G., et al. NADH oxidase activity of mitochondrial apoptosis-inducing factor. J. Biol. Chem. 276 (2001) 16391-16398
147. Moretti L., Yang E.S., Kim K.W., and Lu B. Autophagy signaling in cancer and its potential as novel target to improve anticancer therapy. Drug Resist. Updates 10 (2007) 135-143
148. Moubarak R.S., Yuste V.J., Artus C., Bouharrour A., Greer P.A., Menissier-de Murcia J., and Susin S.A. Sequential activation of poly(ADP-ribose) polymerase 1, calpains, and Bax is essential in apoptosis-inducing factor-mediated programmed necrosis. Mol. Cell. Biol. 27 (2007) 4844-4862
149. Movsesyan V.A., Stoica B.A., and Faden A.I. MGLuR5 activation reduces beta-amyloid-induced cell death in primary neuronal cultures and attenuates translocation of cytochrome c and apoptosis-inducing factor. J. Neurochem. 89 (2004) 1528-1536
150. Munoz-Pinedo C., Guio-Carrion A., Goldstein J.C., Fitzgerald P., Newmeyer D.D., and Green D.R. Different mitochondrial intermembrane space proteins are released during apoptosis in a manner that is coordinately initiated but can vary in duration. Proc. Natl. Acad. Sci. U.S.A. 103 (2006) 11573-11578
151. Nakajima H., Kakui N., Ohkuma K., Ishikawa M., and Hasegawa T. A newly synthesized poly(ADP-ribose)polymerase inhibitor, DR2313 [2-methyl-3,5,7,8- tetrahydro-thio-pyrano[4,3-d]-pyrimidine-4-one]: pharmacological profiles, neuroprotective effects, and therapeutic time window in cerebral ischemia in rats. J. Pharmacol. Exp. Ther. 312 (2005) 472-481
152. Nath R., Raser K.J., Stafford D., Hajimohammadreza I., Posner A., Allen H., et al. Non-erythroid alpha-spectrin breakdown by calpain and interleukin 1 beta-converting-enzyme-like protease(s) in apoptotic cells: contributory roles of both protease families in neuronal apoptosis. Biochem. J. 319 Pt 3 (1996) 683-690
153. Newcomb E.W., Tamasdan C., Entzminger Y., Alonso J., Friedlander D., Crisan D., Miller D.C., and Zagzag D. Flavopiridol induces mitochondrial-mediated apoptosis in murine glioma GL261 cells via release of cytochrome c and apoptosis inducing factor. Cell Cycle 2 (2003) 243-250
154. Nicotera P., Leist M., and Ferrando-May E. Apoptosis and necrosis: different execution of the same death. Biochem. Soc. Symp. 66 (1999) 69-73
155. Nicotera P., Leist M., and Manzo L. Neuronal cell death: a demise with different shapes. Trends Pharmacol. Sci. 20 (1999) 46-51
156. Niikura Y., Dixit A., Scott R., Perkins G., and Kitagawa K. BUB1 mediation of caspase-independent mitotic death determines cell fate. J. Cell Biol. 178 (2007) 283-296
157. Niquet J., Seo D.W., and Wasterlain C.G. Mitochondrial pathways of neuronal necrosis. Biochem. Soc. Trans. 34 (2006) 1347-1351
158. Nishimura Y., Kawabata T., and Kato K. Identification of latent procathepsins B and L in microsomal lumen: characterization of enzymatic activation and proteolytic processing in vitro. Arch. Biochem. Biophys. 261 (1988) 64-71
159. Nomura M., Nomura N., Newcomb E.W., Lukyanov Y., Tamasdan C., and Zagzag D. Geldanamycin induces mitotic catastrophe and subsequent apoptosis in human glioma cells. J. Cell. Physiol. 201 (2004) 374-384
160. Nylandsted J., Gyrd-Hansen M., Danielewicz A., Fehrenbacher N., Lademann U., Hoyer-Hansen M., et al. Heat shock protein 70 promotes cell survival by inhibiting lysosomal membrane permeabilization. J. Exp. Med. 200 (2004) 425-435
161. Okada H., and Mak T.W. Pathways of apoptotic and non-apoptotic death in tumour cells. Nat. Rev. Cancer 4 (2004) 592-603
162. Otera H., Ohsakaya S., Nagaura Z., Ishihara N., and Mihara K. Export of mitochondrial AIF in response to proapoptotic stimuli depends on processing at the intermembrane space. EMBO J. 24 (2005) 1375-1386
163. Pardo J., Perez-Galan P., Gamen S., Marzo I., Monleon I., Kaspar A.A., et al. A role of the mitochondrial apoptosis-inducing factor in granulysin-induced apoptosis. J. Immunol. 167 (2001) 1222-1229
164. Park M.T., Kim M.J., Kang Y.H., Choi S.Y., Lee J.H., Choi J.A., et al. Phytosphingosine in combination with ionizing radiation enhances apoptotic cell death in radiation-resistant cancer cells through ROS-dependent and -independent AIF release. Blood 105 (2005) 1724-1733
165. Park Y.C., Jeong J.H., Park K.J., Choi H.J., Park Y.M., Jeong B.K., Higuchi Y., and Yoo Y.H. Sulindac activates nuclear translocation of AIF. DFF40 and Endonuclease G but not induces oligonucleosomal DNA fragmentation in HT-29 cells. Life Sci. 77 (2005) 2059-2070
166. Perez-Galan P., Marzo I., Giraldo P., Rubio-Felix D., Lasierra P., Larrad L., Anel A., and Naval J. Role of caspases and apoptosis-inducing factor (AIF) in cladribine-induced apoptosis of B cell chronic lymphocytic leukemia. Leukemia 16 (2002) 2106-2114
167. Persson H.L., Yu Z., Tirosh O., Eaton J.W., and Brunk U.T. Prevention of oxidant-induced cell death by lysosomotropic iron chelators. Free Radic. Biol. Med. 34 (2003) 1295-1305
168. Pillai J.B., Russell H.M., Raman J., Jeevanandam V., and Gupta M.P. Increased expression of poly(ADP-ribose) polymerase-1 contributes to caspase-independent myocyte cell death during heart failure. Am. J. Physiol. Heart Circ. Physiol. 288 (2005) H486-H496
169. Plesnila N. Role of mitochondrial proteins for neuronal cell death after focal cerebral ischemia. Acta Neurochir. Suppl. 89 (2004) 15-19
170. Polster B.M., Basanez G., Etxebarria A., Hardwick J.M., and Nicholls D.G. Calpain I induces cleavage and release of apoptosis-inducing factor from isolated mitochondria. J. Biol. Chem. 280 (2005) 6447-6454
171. Ravagnan L., Gurbuxani S., Susin S.A., Maisse C., Daugas E., Zamzami N., et al. Heat-shock protein 70 antagonizes apoptosis-inducing factor. Nat. Cell Biol. 3 (2001) 839-843
172. Reix S., Mechawar N., Susin S.A., Quirion R., and Krantic S. Expression of cortical and hippocampal apoptosis-inducing factor (AIF) in aging and Alzheimer's disease. Neurobiol. Aging 28 (2007) 351-356
173. Roberg K., Kagedal K., and Ollinger K. Microinjection of cathepsin d induces caspase-dependent apoptosis in fibroblasts. Am. J. Pathol. 161 (2002) 89-96
174. Rowan A.D., Mason P., Mach L., and Mort J.S. Rat procathepsin B. Proteolytic processing to the mature form in vitro. J. Biol. Chem. 267 (1992) 15993-15999
175. Ruchalski K., Mao H., Li Z., Wang Z., Gillers S., Wang Y., et al. Distinct hsp70 domains mediate apoptosis-inducing factor release and nuclear accumulation. J. Biol. Chem. 281 (2006) 7873-7880
176. Rugo H., Shtivelman E., Perez A., Vogel C., Franco S., Tan Chiu E., et al. Phase I trial and antitumor effects of BZL101 for patients with advanced breast cancer. Breast Cancer Res. Treat. 105 (2007) 17-28
177. Saelens X., Festjens N., Parthoens E., Vanoverberghe I., Kalai M., van Kuppeveld F., and Vandenabeele P. Protein synthesis persists during necrotic cell death. J. Cell Biol. 168 (2005) 545-551
178. Saez M.E., Ramirez-Lorca R., Moron F.J., and Ruiz A. The therapeutic potential of the calpain family: new aspects. Drug Discov. Today 11 (2006) 917-923
179. Sanges D., Comitato A., Tammaro R., and Marigo V. Apoptosis in retinal degeneration involves cross-talk between apoptosis-inducing factor (AIF) and caspase-12 and is blocked by calpain inhibitors. Proc. Natl. Acad. Sci. U.S.A. 103 (2006) 17366-17371
180. Sanges D., and Marigo V. Cross-talk between two apoptotic pathways activated by endoplasmic reticulum stress: differential contribution of caspase-12 and AIF. Apoptosis 11 (2006) 1629-1641
181. Santiago A.R., Cristovao A.J., Santos P.F., Carvalho C.M., and Ambrosio A.F. High glucose induces caspase-independent cell death in retinal neural cells. Neurobiol. Dis. 25 (2007) 464-472
182. Schapira A.H. Human complex I defects in neurodegenerative diseases. Biochim. Biophys. Acta 1364 (1998) 261-270
183. Schmitt E., Parcellier A., Gurbuxani S., Cande C., Hammann A., Morales M.C., et al. Chemosensitization by a non-apoptogenic heat shock protein 70-binding apoptosis-inducing factor mutant. Cancer Res. 63 (2003) 8233-8240
184. Schweichel J.U., and Merker H.J. The morphology of various types of cell death in prenatal tissues. Teratology 7 (1973) 253-266
185. Shaffer S.A., Baker-Lee C., Kennedy J., Lai M.S., de Vries P., Buhler K., and Singer J.W. In vitro and in vivo metabolism of paclitaxel poliglumex: identification of metabolites and active proteases. Cancer Chemother. Pharmacol. 59 (2007) 537-548
186. Shall S., and de Murcia G. Poly(ADP-ribose) polymerase-1: what have we learned from the deficient mouse model?. Mutat. Res. 460 (2000) 1-15
187. Shapiro G.I. Cyclin-dependent kinase pathways as targets for cancer treatment. J. Clin. Oncol. 24 (2006) 1770-1783
188. Shimizu S., Kanaseki T., Mizushima N., Mizuta T., Arakawa-Kobayashi S., Thompson C.B., and Tsujimoto Y. Role of Bcl-2 family proteins in a non-apoptotic programmed cell death dependent on autophagy genes. Nat. Cell Biol. 6 (2004) 1221-1228
189. Son Y.O., Choi K.C., Lee J.C., Kook S.H., Lee H.J., Jeon Y.M., et al. Involvement of caspase activation and mitochondrial stress in trichostatin A-induced apoptosis of Burkitt's lymphoma cell line. Akata J. Cell. Biochem. 99 (2006) 1420-1430
190. Sorimachi H., and Suzuki K. The structure of calpain. J. Biochem. 129 (2001) 653-664
191. Srivastava S., Banerjee H., Chaudhry A., Khare A., Sarin A., George A., Bal V., Durdik J.M., and Rath S. Apoptosis-inducing factor regulates death in peripheral T cells. J. Immunol. 179 (2007) 797-803
192. Stoka V., Turk B., Schendel S.L., Kim T.H., Cirman T., Snipas S.J., et al. Lysosomal protease pathways to apoptosis. Cleavage of bid, not pro-caspases, is the most likely route. J. Biol. Chem. 276 (2001) 3149-3157
193. Stoka V., Turk B., and Turk V. Lysosomal cysteine proteases: structural features and their role in apoptosis. IUBMB Life 57 (2005) 347-353
194. Strosznajder R., and Gajkowska B. Effect of 3-aminobenzamide on Bcl-2. Bax and AIF localization in hippocampal neurons altered by ischemia-reperfusion injury. the immunocytochemical study. Acta Neurobiol. Exp. 66 (2006) 15-22
195. Susin S.A., Daugas E., Ravagnan L., Samejima K., Zamzami N., Loeffler M., et al. Two distinct pathways leading to nuclear apoptosis. J. Exp. Med. 192 (2000) 571-580
196. Susin S.A., Lorenzo H.K., Zamzami N., Marzo I., Brenner C., Larochette N., Prevost M.C., Alzari P.M., and Kroemer G. Mitochondrial release of caspase-2 and -9 during the apoptotic process. J. Exp. Med. 189 (1999) 381-393
197. Susin S.A., Lorenzo H.K., Zamzami N., Marzo I., Snow B.E., Brothers G.M., et al. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 397 (1999) 441-446
198. Susin S.A., Zamzami N., Castedo M., Daugas E., Wang H.G., Geley S., Fassy F., Reed J.C., and Kroemer G. The central executioner of apoptosis: multiple connections between protease activation and mitochondria in Fas/APO-1/CD95- and ceramide-induced apoptosis. J. Exp. Med. 186 (1997) 25-37
199. Susin S.A., Zamzami N., Castedo M., Hirsch T., Marchetti P., Macho A., et al. Bcl-2 inhibits the mitochondrial release of an apoptogenic protease. J. Exp. Med. 184 (1996) 1331-1341
200. Susin S.A., Zamzami N., and Kroemer G. Mitochondria as regulators of apoptosis: doubt no more. Biochim. Biophys. Acta 1366 (1998) 151-165
201. Susin S.A., Zamzami N., Larochette N., Dallaporta B., Marzo I., Brenner C., Hirsch T., Petit P.X., Geuskens M., and Kroemer G. A cytofluorometric assay of nuclear apoptosis induced in a cell-free system: application to ceramide-induced apoptosis. Exp. Cell Res. 236 (1997) 397-403
202. Takahashi K., Pieper A.A., Croul S.E., Zhang J., Snyder S.H., and Greenberg J.H. Post-treatment with an inhibitor of poly(ADP-ribose) polymerase attenuates cerebral damage in focal ischemia. Brain Res. 829 (1999) 46-54
203. Takano J., Tomioka M., Tsubuki S., Higuchi M., Iwata N., Itohara S., Maki M., and Saido T.C. Calpain mediates excitotoxic DNA fragmentation via mitochondrial pathways in adult brains: evidence from calpastatin mutant mice. J. Biol. Chem. 280 (2005) 16175-16184
204. Tan Y., Dourdin N., Wu C., De Veyra T., Elce J.S., and Greer P.A. Conditional disruption of ubiquitous calpains in the mouse. Genesis 44 (2006) 297-303
205. Terman A., Kurz T., Gustafsson B., and Brunk U.T. Lysosomal labilization. IUBMB Life 58 (2006) 531-539
206. Tezel G., and Yang X. Caspase-independent component of retinal ganglion cell death, in vitro. Invest. Ophthalmol. Vis. Sci. 45 (2004) 4049-4059
207. Thompson C.B. Apoptosis in the pathogenesis and treatment of disease. Science 267 (1995) 1456-1462
208. Thon L., Mathieu S., Kabelitz D., and Adam D. The murine TRAIL receptor signals caspase-independent cell death through ceramide. Exp. Cell Res. 312 (2006) 3808-3821
209. Thon L., Mohlig H., Mathieu S., Lange A., Bulanova E., Winoto-Morbach S., Schutze S., Bulfone-Paus S., and Adam D. Ceramide mediates caspase-independent programmed cell death. FASEB J. 19 (2005) 1945-1956
210. Thornberry N.A., and Lazebnik Y. Caspases: enemies within. Science 281 (1998) 1312-1316
211. Toth-Zsamboki E., Horvath E., Vargova K., Pankotai E., Murthy K., Zsengeller Z., et al. Activation of poly(ADP-ribose) polymerase by myocardial ischemia and coronary reperfusion in human circulating leukocytes. Mol. Med. 12 (2006) 221-228
212. Toyota H., Yanase N., Yoshimoto T., Moriyama M., Sudo T., and Mizuguchi J. Calpain-induced Bax-cleavage product is a more potent inducer of apoptotic cell death than wild-type Bax. Cancer Lett. 189 (2003) 221-230
213. Tsubokawa T., Solaroglu I., Yatsushige H., Cahill J., Yata K., and Zhang J.H. Cathepsin and calpain inhibitor E64d attenuates matrix metalloproteinase-9 activity after focal cerebral ischemia in rats. Stroke 37 (2006) 1888-1894
214. Turk B. Targeting proteases: successes, failures and future prospects. Nat. Rev. Drug Discov. 5 (2006) 785-799
215. Turk B., Turk D., and Turk V. Lysosomal cysteine proteases: more than scavengers. Biochim. Biophys. Acta 1477 (2000) 98-111
216. Turk V., Kos J., and Turk B. Cysteine cathepsins (proteases)-on the main stage of cancer?. Cancer Cell 5 (2004) 409-410
217. Turk V., Turk B., Guncar G., Turk D., and Kos J. Lysosomal cathepsins: structure, role in antigen processing and presentation, and cancer. Adv. Enzyme Regul. 42 (2002) 285-303
218. Uren R.T., Dewson G., Bonzon C., Lithgow T., Newmeyer D.D., and Kluck R.M. Mitochondrial release of pro-apoptotic proteins: electrostatic interactions can hold cytochrome c but not Smac/DIABLO to mitochondrial membranes. J. Biol. Chem. 280 (2005) 2266-2274
219. Vahsen N., Cande C., Briere J., Benit P., Rustin P., and Kroemer G. The absence of apoptosis-inducing factor AIF induces complex I deficiency. Biochim. Biophys. Acta 1657 (2004) 83
220. Vahsen N., Cande C., Briere J.J., Benit P., Joza N., Larochette N., et al. AIF deficiency compromises oxidative phosphorylation. EMBO J. 23 (2004) 4679-4689
221. van Wijk S.J., and Hageman G.J. Poly(ADP-ribose) polymerase-1 mediated caspase-independent cell death after ischemia/reperfusion. Free Radic. Biol. Med. 39 (2005) 81-90
222. Vanden Berghe T., Declercq W., and Vandenabeele P. NADPH oxidases: new players in TNF-induced necrotic cell death. Mol. Cell 26 (2007) 769-771
223. Vanden Berghe T., van Loo G., Saelens X., Van Gurp M., Brouckaert G., Kalai M., Declercq W., and Vandenabeele P. Differential signaling to apoptotic and necrotic cell death by Fas-associated death domain protein FADD. J. Biol. Chem. 279 (2004) 7925-7933
224. Varbiro G., Toth A., Tapodi A., Bognar Z., Veres B., Sumegi B., and Gallyas Jr. F. Protective effect of amiodarone but not N-desethylamiodarone on postischemic hearts through the inhibition of mitochondrial permeability transition. J. Pharmacol. Exp. Ther. 307 (2003) 615-625
225. Virag L., and Szabo C. The therapeutic potential of poly(ADP-ribose) polymerase inhibitors. Pharmacol. Rev. 54 (2002) 375-429
226. Wang H., Yu S.W., Koh D.W., Lew J., Coombs C., Bowers W., Federoff H.J., Poirier G.G., Dawson T.M., and Dawson V.L. Apoptosis-inducing factor substitutes for caspase executioners in NMDA-triggered excitotoxic neuronal death. J. Neurosci. 24 (2004) 10963-10973
227. Wang M., Zhang L., Han X., Yang J., Qian J., Hong S., Samaniego F., Romaguera J., and Yi Q. Atiprimod inhibits the growth of mantle cell lymphoma in vitro and in vivo and induces apoptosis via activating the mitochondrial pathways. Blood 109 (2007) 5455-5462
228. Wang X., Wang J., Gengyo-Ando K., Gu L., Sun C.L., Yang C., et al. C. elegans mitochondrial factor WAH-1 promotes phosphatidylserine externalization in apoptotic cells through phospholipid scramblase SCRM-1. Nat. Cell Biol. 9 (2007) 541-549
229. Wang X., Yang C., Chai J., Shi Y., and Xue D. Mechanisms of AIF-mediated apoptotic DNA degradation in Caenorhabditis elegans. Science 298 (2002) 1587-1592
230. Werneburg N., Guicciardi M.E., Yin X.M., and Gores G.J. TNF-alpha-mediated lysosomal permeabilization is FAN and caspase 8/Bid dependent. Am. J. Physiol. Gastrointest. Liver Physiol. 287 (2004) G436-G443
231. Wesierska-Gadek J., Gueorguieva M., Schloffer D., Uhl M., and Wojciechowski J. Non-apoptogenic killing of hela cervical carcinoma cells after short exposure to the alkylating agent N-methyl-N′-nitro-N-nitrosoguanidine (MNNG). J. Cell. Biochem. 89 (2003) 1222-1234
232. Wissing S., Ludovico P., Herker E., Buttner S., Engelhardt S.M., Decker T., et al. An AIF orthologue regulates apoptosis in yeast. J. Cell Biol. 166 (2004) 969-974
233. Xiao C.Y., Chen M., Zsengeller Z., Li H., Kiss L., Kollai M., and Szabo C. Poly(ADP-ribose) polymerase promotes cardiac remodeling, contractile failure, and translocation of apoptosis-inducing factor in a murine experimental model of aortic banding and heart failure. J. Pharmacol. Exp. Ther. 312 (2005) 891-898
234. Xiao C.Y., Chen M., Zsengeller Z., and Szabo C. Poly(ADP-ribose) polymerase contributes to the development of myocardial infarction in diabetic rats and regulates the nuclear translocation of apoptosis-inducing factor. J. Pharmacol. Exp. Ther. 310 (2004) 498-504
235. Xu Y., Huang S., Liu Z.G., and Han J. Poly(ADP-ribose) polymerase-1 signaling to mitochondria in necrotic cell death requires RIP1/TRAF2-mediated JNK1 activation. J. Biol. Chem. 281 (2006) 8788-8795
236. Yacoub A., Park M.A., Hanna D., Hong Y., Mitchell C., Pandya A.P., et al. OSU-03012 promotes caspase-independent but PERK-, cathepsin B-, BID-, and AIF-dependent killing of transformed cells. Mol. Pharmacol. 70 (2006) 589-603
237. Ye H., Cande C., Stephanou N.C., Jiang S., Gurbuxani S., Larochette N., et al. DNA binding is required for the apoptogenic action of apoptosis inducing factor. Nat. Struct. Biol. 9 (2002) 680-684
238. Yu Q. Restoring p53-mediated apoptosis in cancer cells: new opportunities for cancer therapy. Drug Resist. Updates 9 (2006) 19-25
239. Yu S.W., Andrabi S.A., Wang H., Kim N.S., Poirier G.G., Dawson T.M., and Dawson V.L. Apoptosis-inducing factor mediates poly(ADP-ribose) (PAR) polymer-induced cell death. Proc. Natl. Acad. Sci. U.S.A. 103 (2006) 18314-18319
240. Yu S.W., Wang H., Dawson T.M., and Dawson V.L. Poly(ADP-ribose) polymerase-1 and apoptosis inducing factor in neurotoxicity. Neurobiol. Dis. 14 (2003) 303-317
241. Yu S.W., Wang H., Poitras M.F., Coombs C., Bowers W.J., Federoff H.J., et al. Mediation of poly(ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor. Science 297 (2002) 259-263
242. Yuan J., Lipinski M., and Degterev A. Diversity in the mechanisms of neuronal cell death. Neuron 40 (2003) 401-413
243. Yuste V.J., Moubarak R.S., Delettre C., Bras M., Sancho P., Robert N., d'Alayer J., and Susin S.A. Cysteine protease inhibition prevents mitochondrial apoptosis-inducing factor (AIF) release. Cell Death Differ. 12 (2005) 1445-1448
244. Yuste V.J., Sanchez-Lopez I., Sole C., Moubarak R.S., Bayascas J.R., Dolcet X., Encinas M., Susin S.A., and Comella J.X. The contribution of apoptosis-inducing factor, caspase-activated DNase, and inhibitor of caspase-activated DNase to the nuclear phenotype and DNA. J. Biol. Chem. 280 (2005) 35670-35683
245. Zamzami N., and Kroemer G. The mitochondrion in apoptosis: how Pandora's box opens. Nat. Rev. Mol. Cell. Biol. 2 (2001) 67-71
246. Zamzami N., Susin S.A., Marchetti P., Hirsch T., Gomez-Monterrey I., Castedo M., and Kroemer G. Mitochondrial control of nuclear apoptosis. J. Exp. Med. 183 (1996) 1533-1544
247. Zanna C., Ghelli A., Porcelli A.M., Martinuzzi A., Carelli V., and Rugolo M. Caspase-independent death of Leber's hereditary optic neuropathy cybrids is driven by energetic failure and mediated by AIF and Endonuclease G. Apoptosis 10 (2005) 997-1007
248. Zhang S., Suvannasankha A., Crean C.D., White V.L., Johnson A., Chen C.S., and Farag S.S. OSU-03012, a novel celecoxib derivative, is cytotoxic to myeloma cells and acts through multiple mechanisms. Clin. Cancer Res. 13 (2007) 4750-4758
249. Zhang X., Chen J., Graham S.H., Du L., Kochanek P.M., Draviam R., et al. Intranuclear localization of apoptosis-inducing factor (AIF) and large scale DNA fragmentation after traumatic brain injury in rats and in neuronal cultures exposed to peroxynitrite. J. Neurochem. 82 (2002) 181-191
250. Zhao H., Yenari M.A., Cheng D., Barreto-Chang O.L., Sapolsky R.M., and Steinberg G.K. Bcl-2 transfection via herpes simplex virus blocks apoptosis-inducing factor translocation after focal ischemia in the rat. J. Cereb. Blood Flow Metab. 24 (2004) 681-692
251. Zhu C., Qiu L., Wang X., Hallin U., Cande C., Kroemer G., Hagberg H., and Blomgren K. Involvement of apoptosis-inducing factor in neuronal death after hypoxia-ischemia in the neonatal rat brain. J. Neurochem. 86 (2003) 306-317
252. Zhu C., Wang X., Deinum J., Huang Z., Gao J., Modjtahedi N., et al. Cyclophilin A participates in the nuclear translocation of apoptosis-inducing factor in neurons after cerebral hypoxia-ischemia. J. Exp. Med. 204 (2007) 1741-1748
253. Zhu C., Wang X., Huang Z., Qiu L., Xu F., Vahsen N., et al. Apoptosis-inducing factor is a major contributor to neuronal loss induced by neonatal cerebral hypoxia-ischemia. Cell Death Differ. 14 (2007) 775-784